Inner ear therapy for neural preservation

Audiology and Neurotology

Volumn 11, Issue 6, 2006, Pages 343-356

  Richardson, Rachael T ^a   Noushi, Farnoush ^a   O'Leary, Stephen ^a,b  

^a BIONIC EAR INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cell based therapy; Cochlear implant; Gene therapy; Hair cells; Neurotrophic factors; Round window; Sensorineural hearing loss; Slow release polymers; Spiral ganglion neurons; Vestibular organs

Indexed keywords

ADENOVIRUS VECTOR; ALGINIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CISPLATIN; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GELFOAM; GENTAMICIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; HERPESVIRUS VECTOR; LIPOSOME; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; POLYMER; PREDNISOLONE; VIRUS VECTOR;

ACOUSTIC NERVE FIBER; CATHETERIZATION; CELL DAMAGE; CELL TRANSPLANTATION; COCHLEA; COCHLEA FENESTRA; COCHLEA PROSTHESIS; CYTOTOXICITY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG REEXPOSURE; DRUG RELEASE; DRUG SAFETY; EAR PROTECTION; ELECTROSTIMULATION; ENDOLYMPH; EXPERIMENTAL ANIMAL; GENE EXPRESSION; GUINEA PIG; HAIR CELL; HUMAN; HYDROGEL; INFECTION RISK; INNER EAR; INOCULATION; MENIERE DISEASE; NONHUMAN; OTOTOXICITY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PUMP; REPEAT PROCEDURE; REPORTER GENE; REVIEW; SHORT COURSE THERAPY; SLOW RELEASE FORMULATION; STEM CELL; TRANSGENE; TREATMENT DURATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EAR, INNER; GENE THERAPY; GUINEA PIGS; HAIR CELLS; HEARING LOSS, SENSORINEURAL; HUMANS; INFUSION PUMPS; LABYRINTH DISEASES; NERVE GROWTH FACTORS; NEURONS; PERMEABILITY; ROUND WINDOW; SCALA TYMPANI; SPIRAL GANGLION; STEM CELL TRANSPLANTATION; VESTIBULE;

EID: 33750257265     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000095896     Document Type: Review

References (97)

1. Andrew JK, Fallon JB, Serruto A, Epp SB, Shepherd RK: Protective effects of patterned electrical stimulation on the deafened auditory system. Eleventh Quarterly Progress Report NIH-N01-DC-0-2109 2003.
2. Arriaga MA, Goldman S: Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998;108:1682-1685.
3. Becvarovski Z, Bojrab DI, Michaelides EM, Kartush JM, Zappia JJ, LaRouere MJ: Round window gentamicin absorption: an in vivo human model. Laryngoscope 2002;112:1610-1613.
4. Bowers WJ, Chen X, Guo H, Frisina DR, Federoff HJ, Frisina RD: Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol Ther 2002;6:12-18.
5. Brown JN, Miller JM, Altschuler RA, Nuttall AL: Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 1993;70:167-172.
6. Clark GM: Cochlear Implants: Fundamentals and Applications. New York, Springer, 2003.
7. Coleman B, Hardman J, Coco A, Epp S, de Silva M, Crook J, Shepherd RK: Fate of embryonic stem cell transplanted into the deafened mammalian cochlea. J Cell Transplant 2006;15:369-380.
8. Dazert S, Aletsee C, Brors D, Gravel C, Sendtner M, Ryan A: In vivo adenoviral transduction of the neonatal rat cochlea and middle ear. Hear Res 2001;151:30-40.
9. DeCicco MJ, Hoffer ME, Kopke RD, Wester D, Allen KA, Gottshall K, O'Leary MJ: Round-window microcatheter-administered microdose gentamicin: results from treatment of tinnitus associated with Meniere's disease. Int Tinnitus J 1998;4:141-143.
10. Derby ML, Sena-Esteves M, Breakefield XO, Corey DP: Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999;134:1-8.
11. Edelman ER, Mathiowitz E, Langer R, Klagsbrun M: Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991;12:619-626.
12. Ernfors P, Duan ML, ElShamy WM, Canlon B: Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 1996;2:463-467.
13. Eshraghi AA, Polak M, He J, Telischi FF, Balkany TJ, Van De Water TR: Pattern of hearing loss in a rat model of cochlear implantation trauma. Otol Neurotol 2005;26:442-447; discussion 447.
14. Gillespie LN, Clark GM, Bartlett PF, Marzella PL: BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J Neurosci Res 2003;71:785-790.
15. Gillespie LN, Clark GM, Marzella PL: Delayed neurotrophin treatment supports auditory neuron survival in deaf guinea pigs. Neuroreport 2004;15:1121-1125.
16. Goycoolea MV: Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 2001;121:437-447.
17. Gulya AJ, Steenerson RL: The scala vestibuli for cochlear implantation. An anatomic study. Arch Otolaryngol Head Neck Surg 1996;122:130-132.
18. Hakuba N, Watabe K, Hyodo J, Ohashi T, Eto Y, Taniguchi M, Yang L, Tanaka J, Hata R, Gyo K: Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Ther 2003;10:426-433.
19. Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D: Microdose gentamicin administration via the round window microcatheter: results in patients with Meniere's disease. Ann N Y Acad Sci 2001a;942:46-51.
20. Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, Balaban C: Use of the round window microcatheter in the treatment of Meniere's disease. Laryngoscope 2001b;111:2046-2049.
21. Hu Z, Wei D, Johansson CB, Holmstrom N, Duan M, Frisen J, Ulfendahl M: Survival and neural differentiation of adult neural stem cells transplanted into the mature inner ear. Exp Cell Res 2005;302:40-47.
22. Iguchi F, Nakagawa T, Tateya I, Kim TS, Endo T, Taniguchi Z, Naito Y, Ito J: Trophic support of mouse inner ear by neural stem cell transplantation. Neuroreport 2003;14:77-80.
23. Ishimoto S, Kawamoto K, Kanzaki S, Raphael Y: Gene transfer into supporting cells of the organ of Corti. Hear Res 2002;173:187-197.
24. Ishimoto S, Kawamoto K, Stover T, Kanzaki S, Yamasoba T, Raphael Y: A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol Neurootol 2003;8:70-79.
25. Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, Brough DE, Raphael Y: Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005;11:271-276.
26. Jero J, Mhatre AN, Tseng CJ, Stern RE, Coling DE, Goldstein JA, Hong K, Zheng WW, Hoque AT, Lalwani AK: Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 2001;12:539-548.
27. Kawamoto K, Ishimoto S, Minoda R, Brough DE, Raphael Y: Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003a;23:4395-4400.
28. Kawamoto K, Kanzaki S, Yagi M, Stover T, Prieskorn DM, Dolan DF, Miller JM, Raphael Y: Gene-based therapy for inner ear disease. Noise Health 2001a;3:37-47.
29. Kawamoto K, Oh SH, Kanzaki S, Brown N, Raphael Y: The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 2001b;4:575-585.
30. Kawamoto K, Yagi M, Stover T, Kanzaki S, Raphael Y: Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther 2003b;7:484-492.
31. Keithley EM, Ma CL, Ryan AF, Louis JC, Magal E: GDNF protects the cochlea against noise damage. Neuroreport 1998;9:2183-2187.
32. Kho ST, Pettis RM, Mhatre AN, Lalwani AK: Safety of adeno-associated virus as cochlear gene transfer vector: analysis of distant spread beyond injected cochleae. Mol Ther 2000;2:368-373.
33. Kingma GG, Miller JM, Myers MW: Chronic drug infusion into the scala tympani of the guinea pig cochlea. J Neurosci Methods 1992;45:127-134.
34. Kojima K, Murata M, Nishio T, Kawaguchi S, Ito J: Survival of fetal rat otocyst cells grafted into the damaged inner ear. Acta Otolaryngol Suppl 2004:53-55.
35. Korver KD, Rybak LP, Whitworth C, Campbell KM: Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 2002;126:683-689.
36. Kuang R, Hever G, Zajic G, Yan Q, Collins F, Louis JC, Keithley E, Magal E: Glial cell line-derived neurotrophic factor. Potential for otoprotection. Ann N Y Acad Sci 1999;884:270-291.
37. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M: Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999;100:1865-1871.
38. Lalwani AK, Han JJ, Castelein CM, Carvalho GJ, Mhatre AN: In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 2002;112:1325-1334.
39. Lalwani AK, Han JJ, Walsh BJ, Zolotukhin S, Muzyczka N, Mhatre AN: Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res 1997;114:139-147.
40. Lalwani AK, Walsh BJ, Carvalho GJ, Muzyczka N, Mhatre AN: Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. Am J Otol 1998b;19:390-395.
41. Lalwani A, Walsh B, Reilly P, Carvalho G, Zolotukhin S, Muzyczka N, Mhatre A: Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther 1998a;5:277-281.
42. Lalwani AK, Walsh BJ, Reilly PG, Muzyczka N, Mhatre AN: Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther 1996;3:588-592.
43. Lamm K, Lehnhardt E, Lamm H: Long-term study after perforation of the round window. Animal experiments using electric response audiometry. Acta Otolaryngol 1986;102:27-30.
44. Leake PA, Hradek GT, Snyder RL: Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons after neonatal deafness. J Comp Neurol 1999;412:543-562.
45. Li L, Parkins CW, Webster DB: Does electrical stimulation of deaf cochleae prevent spiral ganglion degeneration? Hear Res 1999;133:27-39.
46. Li Duan M, Bordet T, Mezzina M, Kahn A, Ulfendahl M: Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea. Neuroreport 2002;13:1295-1299.
47. Luebke AE, Foster PK, Muller CD, Peel AL: Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus-and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001a;12:773-781.
48. Luebke AE, Steiger JD, Hodges BL, Amalfitano A: A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther 2001b;8:789-794.
49. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA: Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997;15:631-643.
50. Naito Y, Nakamura T, Nakagawa T, Iguchi F, Endo T, Fujino K, Kim TS, Hiratsuka Y, Tamura T, Kanemaru S, Shimizu Y, Ito J: Transplantation of bone marrow stromal cells into the cochlea of chinchillas. Neuroreport 2004;15:1-4.
51. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y: Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 2004;9:135-143.
52. Noushi F, Richardson RT, Hardman J, Clark G, O'Leary S: Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol Neurotol 2005;26:528-533.
53. Nuttall AL, Marques DM, Lawrence M: Effects of perilymphatic perfusion with neomycin on the cochlear microphonic potential in the guinea pig. Acta Otolaryngol 1977;83:393-400.
54. Paasche G, Gibson P, Averbeck T, Becker H, Lenarz T, Stover T: Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol 2003;24:222-227.
55. Pasic TR, Rubel EW: Rapid changes in cochlear nucleus cell size following blockade of auditory nerve electrical activity in gerbils. J Comp Neurol 1989;283:474-480.
56. Praetorius M, Knipper M, Schick B, Tan J, Limberger A, Carnicero E, Alonso MT, Schimmang T: A novel vestibular approach for gene transfer into the inner ear. Audiol Neurootol 2002;7:324-334.
57. Praetorius M, Limberger A, Muller M, Lehner R, Schick B, Zenner HP, Plinkert P, Knipper M: A novel microperfusion system for the long-term local supply of drugs to the inner ear: implantation and function in the rat model. Audiol Neurootol 2001;6:250-258.
58. Ramsay H, House JR 3rd, Beattie JL, Moore JK: A simple technique for introducing anterograde and retrograde tracers into the vestibular and cochlear sensory organs. Acta Otolaryngol 1996;116:39-43.
59. Raphael Y, Frisancho JC, Roessler BJ: Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett 1996;207:137-141.
60. Richardson RT, Wise A, O'Leary S, Hardman J, Casley D, Clark G: Tracing neurotrophin-3 diffusion and uptake in the guinea pig cochlea. Hear Res 2004;198:25-35.
61. Ruan RS, Leong SK, Mark I, Yeoh KH: Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment. Neuroreport 1999;10:2067-2071.
62. Saijo S, Kimura RS: Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 1984;97:593-610.
63. Sakamoto T, Nakagawa T, Endo T, Kim TS, Iguchi F, Naito Y, Sasai Y, Ito J: Fates of mouse embryonic stem cells transplanted into the inner ears of adult mice and embryonic chickens. Acta Otolaryngol Suppl 2004:48-52.
64. Salt AN: Simulation of methods for drug delivery to the cochlear fluids. Adv Otorhinolaryngol 2002;59:140-148.
65. Salt AN, Ma Y: Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001;154:88-97.
66. Schindler RA, Gladstone HB, Scott N, Hradek GT, Williams H, Shah SB: Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. Am J Otol 1995;16:304-309.
67. Shah S, Gladstone H, Williams H, Hradek G, Schindler R: An extended study: protective effects of nerve growth factor in neomycin-induced auditory neural degeneration. Am J Otol 1995;16:310-314.
68. Shepherd RK, Coco A, Epp SB, Crook JM: Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 2005;486:145-158.
69. Shepherd RK, Xu J: A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion. Hear Res 2002;172:92-98.
70. Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, Kaksonen R, Lindstrom B, Altschuler R, Miller JM: Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci USA 2002;99:1657-1660.
71. Shoji F, Miller AL, Mitchell A, Yamasoba T, Altschuler RA, Miller JM: Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res 2000a;146:134-142.
72. Shoji F, Yamasoba T, Magal E, Dolan DF, Altschuler RA, Miller JM: Glial cell line-derived neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear Res 2000b;142:41-55.
73. Silverstein H: Use of a new device, the Micro-Wick, to deliver medication to the inner ear. Ear Nose Throat J 1999;78:595-598, 600.
74. Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO: Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999;120:649-655.
75. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I: Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996;75:468-471, 474, 476 passim.
76. Staecker H, Gabaizadeh R, Federoff H, Van De Water TR: Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 1998;119:7-13.
77. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR: NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889-894.
78. Staecker H, Li D, O'Malley BW Jr, Van De Water TR: Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol 2001;121:157-163.
79. Stover T, Yagi M, Raphael Y: Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res 1999;136:124-130.
80. Stover T, Yagi M, Raphael Y: Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 2000;7:377-383.
81. Sugahara K, Shimogori H, Yamashita H: The role of acidic fibroblast growth factor in recovery of acoustic trauma. Neuroreport 2001;12:3299-3302.
82. Suzuki R, Okada N, Miyamoto H, Yoshioka T, Sakamoto K, Oka H, Tsutsumi Y, Nakagawa S, Miyazaki J, Mayumi T: Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines. Life Sci 2002;71:1717-1729.
83. Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y: Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther 2000;7:1046-1054.
84. Suzuki M, Yamasoba T, Suzukawa K, Kaga K: Adenoviral vector gene delivery via the round window membrane in guinea pigs. Neuroreport 2003;14:1951-1955.
85. Tamura T, Nakagawa T, Iguchi F, Tateya I, Endo T, Kim TS, Dong Y, Kita T, Kojima K, Naito Y, Omori K, Ito J: Transplantation of neural stem cells into the modiolus of mouse cochleae injured by cisplatin. Acta Otolaryngol Suppl 2004:65-68.
86. Tateya I, Nakagawa T, Iguchi F, Kim TS, Endo T, Yamada S, Kageyama R, Naito Y, Ito J: Fate of neural stem cells grafted into injured inner ears of mice. Neuroreport 2003;14:1677-1681.
87. Wareing M, Mhatre AN, Pettis R, Han JJ, Haut T, Pfister MH, Hong K, Zheng WW, Lalwani AK: Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res 1999;128:61-69.
88. Weiss MA, Frisancho JC, Roessler BJ, Raphael Y: Viral-mediated gene transfer in the cochlea. Int J Dev Neurosci 1997;15:577-583.
89. Wise AK, Richardson R, Hardman J, Clark G, O'Leary S: Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 2005;487:147-165.
90. Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y: Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315-325.
91. Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y: Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999;10:813-823.
92. Yamasoba T, Altschuler RA, Raphael Y, Miller AL, Shoji F, Miller JM: Absence of hair cell protection by exogenous FGF-1 and FGF-2 delivered to guinea pig cochlea in vivo. Noise Health 2001;3:65-78.
93. Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y: Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther 1999;10:769-774.
94. Yeo SW, Gottschlich S, Harris JP, Keithley EM: Antigen diffusion from the perilymphatic space of the cochlea. Laryngoscope 1995;105:623-628.
95. Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, Altschuler R, Miller JM, Saarma M: Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17-26.
96. Youssef TF, Poe DS: Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998;19:435-442.
97. Zhai SQ, Cheng JC, Wang JL, Yang WY, Gu R, Jiang SC: Protective effect of basic fibroblast growth factor on auditory hair cells after noise exposure. Acta Otolaryngol 2002;122:370-373.